Aquestive Therapeutics (AQST) Change in Inventory (2017 - 2026)
Aquestive Therapeutics (AQST) posted quarterly Change in Inventory of $1.9 million for Q1 2026, up 64.3% year-over-year from $1.2 million in Q1 2025, and up 210.62% quarter-over-quarter from -$1.7 million in Q4 2025.
Aquestive Therapeutics (AQST) Change in Inventory (2017 - 2026) Analysis & Trends
Aquestive Therapeutics' Change in Inventory history runs 10 years deep, the most recent figure standing at $1.9 million for Q1 2026.
- In Q1 2026, Change in Inventory rose 64.3% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $868000.0 (up 261.94% YoY), while the FY2025 annual figure was $126000.0, up 117.38% from the prior year.
- Change in Inventory for Q1 2026 stood at $1.9 million, up from -$1.7 million in the prior quarter.
- The five-year high for Change in Inventory was $1.9 million in Q1 2026, with the low at -$1.7 million in Q4 2025.
- The 5-year median for Change in Inventory is $379000.0 (2022), against an average of $237000.0.
- The sharpest annual moves came in 2022 and 2025: Change in Inventory jumped 7054.17% in 2022, then sank 538.18% in 2025.
- Aquestive Therapeutics' Change in Inventory stood at -$944000.0 in 2022, then surged by 67.16% to -$310000.0 in 2023, then plunged by 215.16% to -$977000.0 in 2024, then plunged by 75.44% to -$1.7 million in 2025, then jumped by 210.62% to $1.9 million in 2026.
- Business Quant data shows AQST's Change in Inventory at $1.9 million in Q1 2026, -$1.7 million in Q4 2025, and -$241000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Aquestive Therapeutics | 560.60 Mn | 560.60 Mn | 9.80 Mn | -706,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -706,000.00 |
| Jun 30, 2026 | -706,000.00 |
| Mar 31, 2026 | 1.90 Mn |
| Mar 31, 2026 | 1.90 Mn |
| Dec 31, 2025 | -1.71 Mn |
| Dec 31, 2025 | -1.71 Mn |
| Sep 30, 2025 | -241,000.00 |
| Sep 30, 2025 | -241,000.00 |
| Jun 30, 2025 | 927,000.00 |
| Jun 30, 2025 | 927,000.00 |
| Mar 31, 2025 | 1.15 Mn |
| Mar 31, 2025 | 1.15 Mn |
| Dec 31, 2024 | -977,000.00 |
| Dec 31, 2024 | -977,000.00 |
| Sep 30, 2024 | 55,000.00 |
| Sep 30, 2024 | 55,000.00 |
| Jun 30, 2024 | -768,000.00 |
| Jun 30, 2024 | -768,000.00 |
| Mar 31, 2024 | 965,000.00 |
| Mar 31, 2024 | 965,000.00 |